• About us
    About us

    Zealand Pharma is an international biotechnology company headquartered in Denmark. We are focused on the discovery, design, and development of innovative peptide-based medicines for people who need them.

  • Learn More About us Overview
  • Peptide expertise
  • Partnering
  • Corporate management
  • Board of Directors
  • Corporate governance
  • Our impact
  • Reports & policies
  • Disease areas
    Disease areas

    Zealand Pharma is focused on disease areas where we believe peptide therapies can make a difference for people living with unmet medical needs.

  • Learn More Disease areas Overview
  • Obesity
  • Congenital Hyperinsulinism
  • Short Bowel Syndrome
  • Chronic Inflammation
  • Pipeline
    Pipeline

    At Zealand Pharma, our research and development is directed at generating a pipeline of novel and differentiated peptide candidates.

  • Learn More Pipeline Overview
  • Petrelintide
  • Dapiglutide
  • ZP6590
  • Survodutide
  • Dasiglucagon: Continuous infusion
  • Glepaglutide
  • ZP9830
  • ZP10068
  • Scientific publications
  • Investors
    Investors

    Zealand Pharma is committed to creating value for our society and our shareholders through life-changing peptide therapeutics for people who need them.

  • Learn More Investors Overview
  • Shareholder portal
  • Stock information
  • Financial reports
  • Events & presentations
  • Annual general meeting
  • Analyst coverage
  • FAQs
  • PFIC Annual Information
  • Zeal 371.90 DKK
    -2.80 -0.75%
    Date & Time: 23 June 2025 11:39 (GMT+01:00)
  • News & media
    News & media

    Zealand Pharma provides news through company announcements and press releases.

  • Learn More News & media Overview
  • Newsroom
  • Media resources
  • Subscribe to news
  • Careers
    Careers

    At Zealand Pharma we pride ourselves on the way we work together as one team fostering a strong and engaging company culture founded on collaboration, courage, empowerment, and trust.

  • Learn More Careers Overview
  • Values and culture
  • Meet the Zealanders
  • Interested in a career at Zealand Pharma? View open positions
  • Contact
    Contact
  • Learn More Contact Overview
  • Compliance Hotline
  • results for “”

    Sorry, there are no results for “”

    Try again with different keywords.

  • Company

  • About us
  • Investors
  • News & Media
  • Careers
  • Contact
  • Compliance Hotline
  • Disease Areas

  • Obesity
  • Congenital Hyperinsulinsim
  • Short Bowel Syndrome
  • Chronic inflammation
  • Pipeline

  • Petrelintide
  • Dapiglutide
  • ZP6590
  • Survodutide
  • Dasiglucagon: Continuous infusion
  • Glepaglutide
  • ZP9830
  • ZP10068
  • Follow us

  • LinkedIn
  • © ZEALAND PHARMA
  • Terms of use
  • Privacy notice
  • Accessibility
  • Cookie notice
  • Cookie settings
  • Designed & built by SampsonMay

    You are about to leave Zealand Pharma's website

    The link below goes to a website not owned by Zealand Pharma:
  • Continue to external site
  • Zealand Pharma does not endorse the content of any such third-party website